Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients

PURPOSE: Extension of adjuvant endocrine therapy (ET) reduces the risk of recurrence in women diagnosed with ER-positive breast cancers, but a significant benefit is unlikely to happen to all individual patients. This study is aimed at evaluating the ability of different clinical late distant recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Villasco, Andrea, Accomasso, Francesca, D’Alonzo, Marta, Agnelli, Francesca, Sismondi, Piero, Biglia, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354987/
https://www.ncbi.nlm.nih.gov/pubmed/33939116
http://dx.doi.org/10.1007/s12282-021-01258-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354987/
https://www.ncbi.nlm.nih.gov/pubmed/33939116
http://dx.doi.org/10.1007/s12282-021-01258-5

Ejemplares similares